Entity Details

Primary name ANLN_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9NQW6
EntryNameANLN_HUMAN
FullNameAnillin
TaxID9606
Evidenceevidence at protein level
Length1124
SequenceStatuscomplete
DateCreated2006-03-21
DateModified2021-06-02

Ontological Relatives

GenesANLN

GO terms

Show/Hide Table
GOName
GO:0000281 mitotic cytokinesis
GO:0000915 actomyosin contractile ring assembly
GO:0000921 septin ring assembly
GO:0003779 actin binding
GO:0005654 nucleoplasm
GO:0005826 actomyosin contractile ring
GO:0007096 regulation of exit from mitosis
GO:0015629 actin cytoskeleton
GO:0030496 midbody
GO:0031106 septin ring organization
GO:0032059 bleb
GO:0045296 cadherin binding
GO:0090521 glomerular visceral epithelial cell migration
GO:0099738 cell cortex region
GO:1904172 positive regulation of bleb assembly

Subcellular Location

Show/Hide Table
Subcellular Location
Cell projection
Cytoplasm
Nucleus

Domains

Show/Hide Table
DomainNameCategoryType
IPR001849 Pleckstrin homology domainDomainDomain
IPR011993 PH-like domain superfamilyFamilyHomologous superfamily
IPR012966 Anillin homology domainDomainDomain
IPR031970 Anillin, N-terminal domainDomainDomain
IPR037840 Anillin, PH domainDomainDomain

Diseases

Show/Hide Table
Disease IDSourceNameDescription
616032 OMIMFocal segmental glomerulosclerosis 8 (FSGS8)A renal pathology defined by the presence of segmental sclerosis in glomeruli and resulting in proteinuria, reduced glomerular filtration rate and progressive decline in renal function. Renal insufficiency often progresses to end-stage renal disease, a highly morbid state requiring either dialysis therapy or kidney transplantation. The disease is caused by variants affecting the gene represented in this entry.